0001567619-18-005431.txt : 20181108
0001567619-18-005431.hdr.sgml : 20181108
20181108163427
ACCESSION NUMBER: 0001567619-18-005431
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181106
FILED AS OF DATE: 20181108
DATE AS OF CHANGE: 20181108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harsanyi Zsolt
CENTRAL INDEX KEY: 0001380184
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 181170166
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD., SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
doc1.xml
FORM 4
X0306
4
2018-11-06
0
0001367644
Emergent BioSolutions Inc.
EBS
0001380184
Harsanyi Zsolt
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
1
0
0
0
Common Stock
2018-11-06
4
S
0
8000
68.8992
D
33972
D
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.34 to $69.27, inclusive.
/s/ S. Scott Lieberman, Attorney-in-fact
2018-11-08